Cardlytics (NASDAQ:CDLX) Full Year 2024 Results
Key Financial Results
- Revenue: US$278.3m (down 10.0% from FY 2023).
- Net loss: US$189.3m (loss widened by 41% from FY 2023).
- US$3.91 loss per share (further deteriorated from US$3.69 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Cardlytics Revenues and Earnings Beat Expectations
Revenue exceeded analyst estimates by 3.9%. Earnings per share (EPS) also surpassed analyst estimates by 3.6%.
The primary driver behind last 12 months revenue was the Cardlytics Platform segment contributing a total revenue of US$255.6m (92% of total revenue). Notably, cost of sales worth US$157.4m amounted to 57% of total revenue thereby underscoring the impact on earnings. The most substantial expense, totaling US$125.8m were related to Non-Operating costs. This indicates that a significant portion of the company's costs is related to non-core activities. Explore how CDLX's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 2.7% p.a. on average during the next 2 years, compared to a 2.7% growth forecast for the Media industry in the US.
Performance of the American Media industry.
The company's shares are down 7.6% from a week ago.
Risk Analysis
What about risks? Every company has them, and we've spotted 3 warning signs for Cardlytics (of which 1 shouldn't be ignored!) you should know about.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGM:CDLX
Cardlytics
Operates an advertising platform in the United States and the United Kingdom.
Adequate balance sheet and fair value.
Similar Companies
Market Insights
Community Narratives
